News

Simon-Kucher is proud to be a platinum sponsor of The Chemical Summit We are pleased to share that we will be sponsoring The Chemical Summit on September 29-30, 2026, in Houston, Texas. The Chemical Summit is a two-day conference for senior leaders in the chemicals and materials sector to convene, stay informed on industry trends, and discuss approaches to today’s business concerns. Topics of disc

Simon-Kucher is a proud presenting sponsor for profitABLE 2026: Atlanta by the Professional Pricing Society. Join us at profitABLE26 as we explore future-forward insights on pricing strategies across key themes, including data harmonization, AI monetization, evolving business models, and commercial transformation. We’re excited to connect with peers and leaders in the field at one of the pricing i

Converting performance into value when time is the constraintThe Exit Acceleration Value Creation Plan (VCP) applies to assets within twelve to twenty-four months of a planned exit. At this final stage of ownership, the question is how much value can be credibly realized in the time available.During this phase, time becomes the binding constraint. Initiatives requiring long maturation cycles, orga

What is revenue assurance?Revenue assurance is the process of identifying and correcting hidden revenue leakages and cost inefficiencies across products, partners, and processes. As banks diversify products and partnerships, the complexity of managing true profitability has grown.The idea of revenue assurance can give banks the ability to provide more value without raising prices or cutting servic

The UK has produced some of the world’s most successful neobanks, but domestic growth tells a more nuanced story. New results from our Neobanking Study reveal why high adoption has not yet translated into product depth and business model maturity, and what this means for the next phase of competition.The UK’s place in a global neobanking shiftGlobally, neobanks have moved beyond challenger status.

En un entorno marcado por la volatilidad, la presión sobre los márgenes y clientes cada vez más exigentes, crecer ya no depende únicamente de vender más, sino de construir una propuesta de valor diferenciada, fortalecer las relaciones con los clientes y capturar mejor el valor generado.Simon-Kucher le invita al Encuentro de Liderazgo B2B 2026, un evento exclusivo pensado para reunir a un grupo sel

Three domestic reforms are pushing Korea from the back of the launch queue to the front. For global pharmaceutical companies, South Korea has long been a paradox: clinically sophisticated, fast-growing, and yet often deprioritized in global launch sequencing. Three structural barriers drove this dynamic. First, reimbursement timelines were exceptionally long. Second, conservative cost-effectivenes

In an environment where growth can no longer be taken for granted, value creation has become a central pillar of successful deals. As a result, leading investors are shifting the focus of commercial due diligence from assessing management’s business plan to identifying and actively unlocking additional growth opportunities beyond management’s plans.During this roundtable, we will bring together de

What will define financial resilience for companies in Turkey? Many companies struggle with how resources are allocated. Therefore, moving beyond incremental budgeting and building a culture of cost ownership is becoming critical. Zero-Based Budgeting (ZBB) offers a structured approach to driver smarter spending, stronger discipline, and sustainable growth.The challenges companies in Turkey face –

The P&MA landscape is rapidly increasing in complexity as payers respond to rising healthcare spend. While much recent discussion has focused on policy shifts such as MFN pricing, broader structural changes are reshaping global P&MA. Four trends define this shift: intensified cost containment paired with stricter value-based pricing; stronger linkage between reimbursement and local investment; str

While the OCFO software market shows strong underlying growth, investor attractiveness – beyond generic target selection parameters such as ticket size/EV and investment strategy – is ultimately determined by exposure to high-growth segments and company-specific capabilities. These can be assessed across five key characteristics to identify the most attractive segments. In addition, attractive OCF

Recent pressure on software valuations – driven in part by investor concerns around AI disruption – has led to more cautious investment behavior and multiple compression across the software industry. The average forward earnings multiple for software companies collapsed from roughly 39x to about 21x in just a few months and the IGV Software Index is already down more than 30 percent from its late-

As AI becomes an integrated tool for trip planning, the US travel market has undergone a new phase of structural change. US travelers are shifting their travel perceptions by planning trips earlier, adhering to travel budgets despite economic pressures, and prioritizing domestic trips. Price flexibility, social media influence, and targeted ROI focused business travel are further reshaping US book

.page-img { width: 100%;}This article marks the first in a three-part series exploring some of the most pressing sustainability topics in healthcare today. Here, we examine how sustainability principles are reshaping procurement, market access, and pricing across the healthcare sector.  Introduction to sustainability in healthcare procurement & pricingThe healthcare sector alone accounts for roug

Simon-Kucher te invita a la 2ª edición del Foro de Estrategia Comercial 2026: una serie de encuentros presenciales para líderes que buscan acelerar el crecimiento rentable. En esta edición los especialistas de Simon-Kucher abordaran temas clave para la gestión comercial frente a un entorno cada vez más desafiante:Visión del cliente para decisiones estratégicas: Revenue Pools y gestión de portafoli

Access in low- and middle-income countries (LMICs) has long depended on donor-funded programs, one-off partnerships, and isolated pricing initiatives. While these approaches delivered varying levels of success, they were not designed for scale or sustainability. With more than 80% of the world’s population living in LMICs, equitable access is becoming a strategic necessity for pharmaceutical compa